V-antigen homologs in pathogenic gram-negative bacteria

Microbiology and Immunology

Volumn 58, Issue 5, 2014, Pages 267-285

  Sawa, Teiji ^a   Katoh, Hideya ^a   Yasumoto, Hiroaki ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Pseudomonas; Type III secretion system; V antigen; Yersinia

Indexed keywords

BACTERIAL PROTEIN; LCRV PROTEIN; PCRV PROTEIN; PROTEIN ANTIBODY; REGULATOR PROTEIN; UNCLASSIFIED DRUG; V ANTIGEN; V ANTIGEN ANTIBODY; YOP PROTEIN; ANTIGEN V, PSEUDOMONAS; BACTERIAL ANTIGEN; BACTERIAL TOXIN; BACTERIAL VACCINE; LCRV PROTEIN, YERSINIA; PORE FORMING CYTOTOXIC PROTEIN;

AEROMONAS; AMINO TERMINAL SEQUENCE; ANTIGEN DETECTION; ANTIGEN STRUCTURE; BACTERIUM IDENTIFICATION; CARBOXY TERMINAL SEQUENCE; DNA SEQUENCE; GRAM NEGATIVE BACTERIUM; HUMAN; IMMUNOTHERAPY; MOLECULAR DYNAMICS; NONHUMAN; NUCLEOTIDE SEQUENCE; PHOTORHABDUS LUMINESCENS; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SECRETION; PROTEIN TERTIARY STRUCTURE; PSEUDOMONAS AERUGINOSA; REVIEW; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS; TYPE III SECRETION SYSTEM; VIBRIO; YERSINIA; ANIMAL; CHEMISTRY; GENETICS; GRAM-NEGATIVE BACTERIAL INFECTIONS; IMMUNOLOGY; MICROBIOLOGY; SEQUENCE HOMOLOGY; VETERINARY;

ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL TOXINS; BACTERIAL VACCINES; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; PORE FORMING CYTOTOXIC PROTEINS; SEQUENCE HOMOLOGY;

EID: 84899922148     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/1348-0421.12147     Document Type: Review

References (137)

1. Burrows T.W., Bacon G.A. ( 1954) The basis of virulence in Pasteurella pestis: attempts to induce mutation from avirulence to virulence. Br J Exp Pathol 35: 129-33.
2. Burrows T.W., Bacon G.A. ( 1956) The basis of virulence in Pasteurella pestis: an antigen determining virulence. Br J Exp Pathol 37: 481-93.
3. Burrows T.W. ( 1956) An antigen determining virulence in Pasteurella pestis. Nature (London) 177: 426-7.
4. Burrows T.W., Bacon G.A. ( 1958) The effects of loss of virulence determinants on the virulence and immunogenicity of strains of Pasteurella pestis. Br J Exp Pathol 39: 278-91.
5. Burrows T.W. ( 1960) Biochemical properties of virulent and avirulent strains of bacteria: Salmonella typhosa and Pasteurella pestis. Ann NY Acad Sci 88: 1125-35.
6. Lawton W.D., Erdman R.L., Surgalla M.J. ( 1963) Biosynthesis and purification of V and W antigen in Pasteurella pestis. J Immunol 91: 179-84.
7. Carter P.B., Zahorchak R.J., Brubaker R.R. ( 1980) Plague virulence antigens from Yersinia enterocolitica. Infect Immun 28: 638-40.
8. 2+ dependence and V antigen synthesis in Yersinia pestis. Infect Immun 38: 953-9.
9. ++. Rev Infect Dis 5: S748-58.
10. + phenotype of Yersinia enterocolitica. Infect Immun 40: 166-71.
11. Mulder B., Michiels T., Simonet M., Sory M.P., Cornelis G. ( 1989) Identification of additional virulence determinants on the pYV plasmid of Yersinia enterocolitica W227. Infect Immun 57: 2534-41.
12. Une T., Brubaker R.R. ( 1984) Roles of V antigen in promoting virulence and immunity in yersiniae. J Immunol 133: 2226-30.
13. 2+-blind mutants of Yersinia pestis. J Bacteriol 164: 704-11.
14. 2+ response operon encodes the V antigen of Yersinia pestis. Infect Immun 54: 428-34.
15. 2+ in Yersinia pestis include structural genes for outer membrane proteins. Infect Immun 51: 445-54.
16. Price S.B., Leung K.Y., Barve S.S., Straley S.C. ( 1989) Molecular analysis of lcrGVH, the V antigen operon of Yersinia pestis. J Bacteriol 171: 5646-53.
17. Forsberg A., Bolin I., Norlander L., Wolf-Watz H. ( 1987) Molecular cloning and expression of calcium-regulated, plasmid-coded proteins of Y. pseudotuberculosis. Microb Pathog 2: 123-37.
18. Bergman T., Hakansson S., Forsberg A., Norlander L., Macellaro A., Backman A., Bolin I., Wolf-Watz H. ( 1991) Analysis of the V-antigen lcrGVH-yopBD operon of Yersinia pseudotuberculosis: evidence for a regulatory role of LcrH and LcrV. J Bacteriol 173: 1607-16.
19. Brubaker R.R. ( 2003) Interleukin-10 and inhibition of innate immunity to Yersiniae: roles of Yops and LcrV (V antigen). Infect Immun 71: 3673-81.
20. Cornelis G.R., Wolf-Watz H. ( 1997) The Yersinia Yop virulon: a bacterial system for subverting eukaryotic cells. Mol Microbiol 23: 861-7.
21. Hueck C.J. ( 1998) Type III protein secretion systems in bacterial pathogens of animals and plants. Microbiol Mol Biol Rev 62: 379-433.
22. Nilles M.L., Fields K.A., Straley S.C. ( 1998) The V antigen of Yersinia pestis regulates Yop vectorial targeting as well as Yop secretion through effects on YopB and LcrG. J Bacteriol 180: 3410-20.
23. Sarker M.R., Neyt C., Stainier I., Cornelis G.R. ( 1998) The Yersinia Yop virulon: LcrV is required for extrusion of the translocators YopB and YopD. J Bacteriol 180: 1207-14.
24. Pettersson J., Holmstrom A., Hill J., Leary S., Frithz-Lindsten E., Von Euler-Matell A., Carlsson E., Titball R., Forsberg A., Wolf-Watz H. ( 1999) The V-antigen of Yersinia is surface exposed before target cell contact and involved in virulence protein translocation. Mol Microbiol 32: 961-76.
25. 2+ response virulence genes. J Bacteriol 173: 2649-57.
26. Dacheux D., Goure J., Chabert J., Usson Y., Attree I. ( 2001) Pore-forming activity of type III system-secreted proteins leads to oncosis of Pseudomonas aeruginosa-infected macrophages. Mol Microbiol 40: 76-85.
27. Holmstrom A., Olsson J., Cherepanov P., Maier E., Nordfelth R., Pettersson J., Benz R., Wolf-Watz H., Forsberg A. ( 2001) LcrV is a channel size-determining component of the Yop effector translocon of Yersinia. Mol Microbiol 39: 620-32.
28. Nakajima R., Brubaker R.R. ( 1993) Association between virulence of Yersinia pestis and suppression of gamma interferon and tumor necrosis factor-alpha. Infect Immun 61: 23-31.
29. Nakajima R., Motin V.L., Brubaker R.R. ( 1995) Suppression of cytokines in mice by protein A-V antigen fusion peptide and restoration of synthesis by active immunization. Infect Immun 63: 3021-9.
30. Welkos S., Friedlander A.M., Mcdowell D., Weeks J., Tobery S. ( 1998) V antigen of Yersinia pestis inhibits neutrophil chemotaxis. Microb Pathog 24: 328-42.
31. Yahr T.L., Mendemueller L.M., Friese M.B., Frank D.W. ( 1997) Identification of type III secreted products of the Pseudomonas aeruginosa exoenzyme S regulon. J Bacteriol 179: 7165-8.
32. Sawa T., Yahr T.L., Ohara M., Kurahashi K., Gropper M.A., Wiener-Kronish J.P., Frank D.W. ( 1999) Active and passive immunization with the Pseudomonas V antigen protects against type III intoxication and lung injury. Nat Med 5: 392-8.
33. Holder I.A., Neely A.N., Frank D.W. ( 2001) PcrV immunization enhances survival of burned Pseudomonas aeruginosa-infected mice. Infect Immun 69: 5908-10.
34. Brubaker R.R. ( 1999) For Pseudomonas aeruginosa, stealth is no longer enough. Nat Med 5: 378-9.
35. Ffrench-Constant R., Waterfield N., Daborn P., Joyce S., Bennett H., Au C., Dowling A., Boundy S., Reynolds S., Clarke D. ( 2003) Photorhabdus: towards a functional genomic analysis of a symbiont and pathogen. FEMS Microbiol Rev 26: 433-56.
36. Makino K., Oshima K., Kurokawa K., Yakoyama K., Uda T., Tagomori K., Iijima Y., Najima M., Nakano M., Yamashita A., Kubota Y., Kimura S., Yasunaga T., Honda T., Shinagawa H., Hattori M., Iida T. ( 2003) Genome sequence of Vibrio parahaemolyticus: a pathogenic mechanism distinct from that of V. cholerae. Lancet 361: 743-9.
37. Henke J.M., Bassler B.L. ( 2004) Quorum sensing regulates Type III secretion in Vibrio harveyi and Vibrio parahaemolyticus. J Bacteriol 186: 3794-805.
38. Stuber K., Burr S.E., Braun M., Wahli T., Frey J. ( 2003) Type III secretion genes in Aeromonas salmonicida subsp salmonicida are located on a large thermolabile virulence plasmid. J Clin Microbiol 41: 3854-6.
39. Chacon M.R., Soler L., Groisman E.A., Guarro J., Figueras M.J. ( 2004) Type III secretion system genes in clinical Aeromonas isolates. J Clin Microbiol 42: 1285-7.
40. 2+ response, and virulence of Yersinia pestis. J Bacteriol 177: 2530-42.
41. Ligtenberg K.G., Miller N.C., Mitchell A., Plano G.V., Schneewind O. ( 2013) LcrV mutants that abolish Yersinia type III injectisome function. J Bacteriol 195: 777-87.
42. Skryzpek E., Straley S.C. ( 1993) LcrG, a secreted protein involved in negative regulation of the low-calcium response in Yersinia pestis. J Bacteriol 175: 3520-8.
43. Debord K.L., Lee V.T., Schneewind O. ( 2001) Roles of LcrG and LcrV during type III targeting of effector Yops by Yersinia enterocolitica. J Bacteriol 183: 4588-98.
44. 2+ response. J Bacteriol 179: 1307-16.
45. Matson J.S., Nilles M.L. ( 2001) LcrG-LcrV interaction is required for control of Yops secretion in Yersinia pestis. J Bacteriol 183: 5082-91.
46. Matson J.S., Nilles M.L. ( 2002) Interaction of the Yersinia pestis type III regulatory proteins LcrG and LcrV occurs at a hydrophobic interface. BMC Microbiol 2: 1-12.
47. Allmond L.R., Karaca T.J., Nguyen V.N., Nguyen T., Wiener-Kronish J.P., Sawa T. ( 2003) Protein binding between PcrG-PcrV and PcrH-PopB/PopD encoded by the pcrGVH-popBD operon of the Pseudomonas aeruginosa Type III secretion system. Infect Immun 71: 2230-3.
48. Yahr T.L., Goranson J., Frank D.W. ( 1996) Exoenzyme S of Pseudomonas aeruginosa is secreted by a type III pathway. Mol Microbiol 22: 991-1003.
49. Frank D.W. ( 1997) The exoenzyme S regulon of Pseudomonas aeruginosa. Mol Microbiol 26: 621-9.
50. Shime N., Sawa T., Fujimoto J., Faure K., Allmond L.R., Karaca T., Swanson B.L., Spack E.G., Wiener-Kronish J.P. ( 2001) Therapeutic administration of anti-PcrV F(ab')(2) in sepsis associated with Pseudomonas aeruginosa. J Immunol 167: 5880-6.
51. Frank D.W., Vallis A., Wiener-Kronish J.P., Roy-Burman A., Spack E.G., Mullaney B.P., Megdoud M., Marks J.D., Fritz R., Sawa T. ( 2002) Generation and characterization of a protective monoclonal antibody to Pseudomonas aeruginosa PcrV. J Infect Dis 186: 64-73.
52. Faure K., Fujimoto J., Shimabukuro D.W., Ajayi T., Shime N., Moriyama K., Spack E.G., Wiener-Kronish J.P., Sawa T. ( 2003) Effects of monoclonal anti-PcrV antibody on Pseudomonas aeruginosa-induced acute lung injury in a rat model. J Immune Based Ther Vaccines 1: 2.
53. Baer M., Sawa T., Flynn P., Luehrsen K., Martinez D., Wiener-Kronish J.P., Yarranton G., Bebbington C. ( 2009) An engineered human antibody Fab fragment specific for Pseudomonas aeruginosa PcrV antigen has potent antibacterial activity. Infect Immun 77: 1083-90.
54. Francois B., Luyt C.E., Dugard A., Wolff M., Diehl J.L., Jaber S., Forel J.M., Garot D., Kipnis E., Mebazaa A., Misset B., Andremont A., Ploy M.C., Jacobs A., Yarranton G., Pearce T., Fagon J.Y., Chastre J. ( 2012) Safety and pharmacokinetics of an anti-PcrV PEGylated monoclonal antibody fragment in mechanically ventilated patients colonized with Pseudomonas aeruginosa: a randomized, double-blind, placebo-controlled trial. Crit Care Med 40: 2320-6.
55. Milla C.E., Chmiel J.F., Accurso F.J., Vandevanter D.R., Konstan M.W., Yarranton G., Geller D.E., 2013 for The KB 001 Study Group. Anti-PcrV antibody in cystic fibrosis: a novel approach targeting Pseudomonas aeruginosa airway infection Pediat Pulmonol doi:10.1002/ppul.22890 [Epub ahead of print].
56. Hakansson S., Schesser K., Persson C., Galyov E.E., Rosqvist R., Homble F., Wolf-Watz H. ( 1996) The YopB protein of Yersinia pseudotuberculosis is essential for the translocation of Yop effector proteins across the target cell plasma membrane and displays a contact-dependent membrane disrupting activity. EMBO J 15: 5812-23.
57. Hakansson S., Bergman T., Vanooteghem J.C., Cornelis G., Wolf-Watz H. ( 1993) YopB and YopD constitute a novel class of Yersinia Yop proteins. Infect Immun 61: 71-80.
58. Neyt C., Cornelis G.R. ( 1999) Role of SycD, the chaperone of the Yersinia Yop translocators YopB and YopD. Mol Microbiol 31: 143-56.
59. Nordfelth R., Wolf-Watz H. ( 2001) YopB of Yersinia enterocolitica is essential for YopE translocation. Infect Immun 69: 3516-8.
60. Schoehn G., Di Guilmi A.M., Lemaire D., Attree I., Weissenhorn W., Dessen A. ( 2003) Oligomerization of Type III secretion proteins PopB and PopD precedes pore formation in Pseudomonas. EMBO J 22: 4957-67.
61. Fields K.A., Nilles M.L., Cowan C., Straley S.C. ( 1999) Virulence role of V antigen of Yersinia pestis at the bacterial cell surface. Infect Immun 67: 5395-408.
62. Goure J., Pastor A., Faudry E., Chabert J., Dessen A., Attree I. ( 2004) The V antigen of Pseudomonas aeruginosa is required for assembly of the functional PopB/PopD translocation pore in host cell membranes. Infect Immun 72: 4741-50.
63. Mueller C.A., Broz P., Muller S.A., Ringler P., Erne-Brand F., Sorg I., Kuhn M., Engel A., Cornelis G.R. ( 2005) The V-antigen of Yersinia forms a distinct structure at the tip of injectisome needles. Science 310: 674-6.
64. Motin V.L., Nakajima R., Smirnov G.B., Brubaker R.R. ( 1994) Passive immunity to Yersiniae mediated by anti-recombinant V antigen and protein A-V antigen fusion peptide. Infect Immun 62: 4192-201.
65. Schmidt A., Rollinghoff M., Beuscher H.U. ( 1999) Suppression of TNF by V antigen of Yersinia spp. involves activated T cells. Eur J Immunol 29: 1149-57.
66. Sing A., Roggenkamp A., Geiger A.M., Heesemann J. ( 2002) Yersinia enterocolitica evasion of the host innate immune response by V antigen-induced IL-10 production of macrophages is abrogated in IL-10-deficient mice. J Immunol 168: 1315-21.
67. Sawa T., Corry D.B., Gropper M.A., Ohara M., Kurahashi K., Wiener-Kronish J.P. ( 1997) IL-10 improves lung injury and survival in Pseudomonas aeruginosa pneumonia. J Immunol 159: 2858-66.
68. Reithmeier-Rost D., Hill J., Elvin S.J., Williamson D., Dittmann S., Schmid A., Wilharm G., Sing A. ( 2007) The weak interaction of LcrV and TLR2 does not contribute to the virulence of Yersinia pestis. Microb Infect Institut Pasteur 9: 997-1002.
69. Pouliot K., Pan N., Wang S., Lu S., Lien E., Goguen J.D. ( 2007) Evaluation of the role of LcrV-Toll-like receptor 2-mediated immunomodulation in the virulence of Yersinia pestis. Infect Immun 75: 3571-80.
70. Sun W., Curtiss R.I. ( 2012) Amino acid substitutions in LcrV at putative sites of interaction with Toll-like receptor 2 do not affect the virulence of Yersinia pestis. Microb Pathog 53: 198-206.
71. Russell P., Eley S.M., Hibbs S.E., Manchee R.J., Stagg A.J., Titball R.W. ( 1995) A comparison of plague vaccine USP and EV76 vaccine induced protection against Yersinia pestis in a murine model. Vaccine 13: 1551-6.
72. Meyer K.F. ( 1970) Effectiveness of live or killed plague vaccines in man. Bull World Health Organ 4: 653-66.
73. Marshall J.D., Bartelloni P.J., Cavanaugh D.C., Kadull P.J., Meyer K.F. ( 1974) Plague immunization. II. Relation of adverse clinical reactions to multiple immunisations with killed vaccine. J Infect Dis 129: S19-25.
74. National Center on Minority Health and Health Disparities USA. ( 2002) NIAID biodefense research agenda for CDC category A agents. U.S. Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases, NIH Publication No. 03-5308.
75. Meyer K.F., Hightower J.A., Mccrumb F.R. ( 1974) Plague immunization. VI. Vaccination with the Fraction1 antigen of Yersinia pestis. J Infect Dis 129: S41-5.
76. Straley S.C., Brubaker R.R. ( 1982) Localization in Yersinia pestis of peptides associated with virulence. Infect Immun 36: 129-35.
77. Leary S.E.C., Wiiliamson E.D., Griffin K.F., Russell P., Eley S.M., Titball R.W. ( 1995) Active immunization with recombinant V antigen from Yersinia pesitis protects mice against plague. Infect Immun 63: 2854-8.
78. Anderson G.W., Leary S.E.C., Williamson E.D., Titball R.W., Welkos S.L., Worsham P.L., Friedlander A.M. ( 1996) Recombinant V antigen protects mice against pneumonic and bubonic plague against F1 capsule positive and negative strains of Y. pestis. Infect Immun 64: 4580-5.
79. Sato K., Nakajima R., Hara F., Une T., Osada Y. ( 1991) Preparation of monoclonal antibody to V antigen from Yersinia pestis. Contrib Microbiol Immunol 12: 225-9.
80. Williamson E.D., Eley S.M., Griffin K.F., Green M., Russell P., Leary S.E., Oyston P.C., Easterbrook T., Reddin K.M., Robinson A., Titball R.W. ( 1995) A new improved sub-unit vaccine for plague: the basis of protection. FEMS Immunol Med Microbiol 12: 223-30.
81. Williamson E.D., Sharpe G.J.E., Eley S.M., Vesey P.M., Pepper T.C., Titball R.W., Alpar H.O. ( 1996) Local and systemic immune response to a microencapsulated sub-unit vaccine for plague. Vaccine 14: 1613-9.
82. Williamson E.D., Vesey P.M., Gilhespy K.J., Eley S.M., Green M., Titball R.W. ( 1999) An IgG1 titre to the F1 and V antigens correlates with protection against plague in the mouse model. Clin Exp Immunol 116: 107-14.
83. Eyles J.E., Williamson E.D., Spiers I.D., Stagg A.J., Jones S.M., Alpar H.O. ( 2000) Generation of protective immune responses to plague by mucosal administration of microsphere coencapsulated recombinant subunits. J Control Release 63: 191-200.
84. Heath D.G., Anderson G.W.J., Mauro M., Welkos S., Andrews G.P., Adamovicz J., Friedlander A.M. ( 1998) Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine. Vaccine 16: 1131-7.
85. BBC News Black Death vaccine developed. [Cited 19 Feb 2004.] Available from URL: http://news.bbc.uk/2/hi/health/3502361.stm.
86. Roggenkamp A., Geiger A.M., Leitritz L., Kessler A., Heesemann J. ( 1997) Passive immunity to infection with Yersinia spp. mediated by anti-recombinant V antigen is dependent on polymorphism of V antigen. Infect Immun 65: 446-51.
87. Schmidt A., Schaffelhofer S., Müller K., Rollinghoff M., Beuscher H.U. ( 1999) Analysis of the Yersinia enterocolitica 0:8 V antigen for cross protectivity. Microb Pathog 26: 221-33.
88. Hill J., Leary S.E.C., Griffin K.F., Williamson E.D., Titball R.W. ( 1997) Regions of Yersinia pestis V antigen that contribute to protection against plague identified by passive and active immunization. Infect Immun 65: 4476-82.
89. Gerrard J.G., Mcnevin S., Alfredson D., Forgan-Smith R., Fraser N. ( 2003) Photorhabdus species: bioluminescent bacteria as emerging human pathogens? Emerg Infect Dis 9: 251-4.
90. Waterfield N.R., Daborn P.J., Ffrench-Constant R.H. ( 2002) Genomic islands in Photorhabdus. Trends Microbiol 10: 541-5.
91. Duchaud E., Rusniok C., Frangeul L., Buchrieser C., Givaudan A., Taourit S., Bocs S., Boursaux-Eude C., Chandler M., Charles J.F., Dassa E., Derose R., Derzelle S., Freyssinet G., Gaudriault S., Medigue C., Lanois A., Powell K., Siguier P., Vincent R., Wingate V., Zouine M., Glaser P., Boemare N., Danchin A., Kunst F. ( 2003) The genome sequence of the entomopathogenic bacterium Photorhabdus luminescens. Nat Biotechnol 21: 1307-13.
92. Silva C.P., Waterfield N.R., Daborn P.J., Dean P., Chilver T., Au C.P., Sharma S., Potter U., Reynolds S.E., Ffrench-Constant R.H. ( 2002) Bacterial infection of a model insect: Photorhabdus luminescens and Manduca sexta. Cell Microbiol 4: 329-39.
93. Mccarter L. ( 1999) The multiple identities of Vibrio parahaemolyticus. J Mol Microbiol Biotechnol 1: 51-7.
94. Vandenberghe J., Verdonck L., Robles-Arozarena R., Rivera G., Bolland A., Balladares M., Gomez-Gil B., Calderon J., Sorgeloos P., Swings J. ( 1999) Vibrios associated with Litopenaeus vannamei larvae, postlarvae, broodstock, and hatchery probionts. Appl Environ Microbiol 65: 2592-7.
95. Dunlap P.V. ( 1999) Quorum regulation of luminescence in Vibrio fischeri. J Mol Microbiol Biotechnol 1: 5-12.
96. Karunasagar I., Pai R., Malathi G.R., Karunasagar I. ( 1994) Mass mortality of Penaeus monodon larvaedue to antibiotic-resistant Vibrio harveyi infection. Aquaculture 128: 203-9.
97. Liu P.C., Lee K.K., Yii K.C., Kou G.H., Chen S.N. ( 1996) Isolation of Vibrio harveyi from diseased kuruma prawns Penaeus japonicus. Curr Microbiol 33: 129-32.
98. Zen-Yoji H., Le Clair R.A., Ota K., Montague T.S. ( 1973) Comparison of Vibrio parahaemolyticus cultures isolated in the United States with those isolated in Japan. J Infect Dis 127: 237-41.
99. Zhao Z., Zhang L., Ren C., Zhao J., Chen C., Jiang X., Luo P., Hu C.Q. ( 2011) Autophagy is induced by the Type III secretion system of Vibrio alginolyticus in several mammalian cell lines. Arch Microbiol 193: 53-61.
100. Zhao Z., Chen C., Hu C.Q., Ren C.H., Zhao J.J., Zhang L.P., Jiang X., Luo P., Wang Q.B. ( 2010) The Type III secretion system of Vibrio alginolyticus induces rapid apoptosis, cell rounding and osmotic lysis of fish cells. Microbiology 156: 2864-72.
101. Braun M., Stuber K., Schlatter Y., Wahli T., Kuhnert P., Frey J. ( 2002) Characterization of an ADP-ribosyl transferase toxin (AexT) from Aeromonas salmonicida subsp. salmonicida. J Bacteriol 184: 1851-8.
102. Burr S.E., Stuber K., Wahli T., Frey J. ( 2002) Evidence for a Type III secretion system in Aeromonas salmonicida subsp. salmonicida. J Bacteriol 184: 5966-70.
103. Burr S.E., Stuber K., Frey J. ( 2003) The ADP-ribosylating toxin, AexT, from Aeromonas salmonicida subsp. salmonicida is translocated via a Type III secretion pathway. J Bacteriol 185: 6583-91.
104. Bergh P.V., Burr S.E., Benedicenti O., Von Siebenthal B., Frey J., Wahli T. ( 2013) Antigens of the type-three secretion system of Aeromonas salmonicida subsp. salmonicida prevent protective immunity in rainbow trout. Vaccine 31: 5256-61.
105. Austin B., Austin D.A.( 1987) Motile Aeromonads. 1st edn. Chichester, UK: Ellis Horwood.
106. Vila J., Ruiz J., Gallardo F., Vargas M., Soler L., Figueras M.J., Gascon J. ( 2003) Aeromonas spp. and traveler's diarrhea: clinical features and antimicrobial resistance. Emerg Infect Dis 9: 552-5.
107. Juan H.J., Tang R.B., Wu T.C., Yu K.W. ( 2000) Isolation of Aeromonas hydrophila in children with diarrhea. J Microbiol Immunol Infect 33: 115-7.
108. Barillo D.J., Mcmanus A.T., Cioffi W.G., Mcmanus W.F., Kim S.H., Pruitt B.A., Jr. ( 1996) Aeromonas bacteraemia in burn patients. Burns 22: 48-52.
109. Yu H.B., Rao P.S., Lee H.C., Vilches S., Merino S., Tomas J.M., Leung K.Y. ( 2004) A Type III secretion system is required for Aeromonas hydrophila AH-1 pathogenesis. Infect Immun 72: 1248-56.
110. Nikolaus T., Deiwick J., Rappl C., Freeman J.A., Schroder W., Miller S.I., Hensel M. ( 2001) SseBCD proteins are secreted by the Type III secretion system of Salmonella pathogenicity island 2 and function as a translocon. J Bacteriol 183: 6036-45.
111. Sekiya K., Ohishi M., Ogino T., Tamano K., Sasakawa C., Abe A. ( 2001) Supermolecular structure of the enteropathogenic Escherichia coli Type III secretion system and its direct interaction with the EspA-sheath-like structure. Proc Natl Acad Sci USA 98: 11638-43.
112. Medhekar B., Shrivastava R., Mattoo S., Gingery M., Miller J.F. ( 2009) Bordetella Bsp22 forms a filamentous Type III secretion system tip complex and is immunoprotective in vitro and in vivo. Mol Microbiol 71: 492-504.
113. Zurawski D.V., Stein M.A. ( 2003) SseA acts as the chaperone for the SseB component of the Salmonella pathogenicity island 2 translocon. Mol Microbiol 47: 1341-51.
114. Ruiz-Albert J., Mundy R., Yu X.J., Beuzon C.R., Holden D.W. ( 2003) SseA is a chaperone for the SseB and SseD translocon components of the Salmonella pathogenicity-island-2-encoded Type III secretion system. Microbiology 149: 1103-11.
115. Aizawa S.I. ( 2001) Bacterial flagella and Type III secretion systems. FEMS Microbiol Lett 202: 157-64.
116. Blocker A., Komoriya K., Aizawa S. ( 2003) Type III secretion systems and bacterial flagella: insights into their function from structural similarities. Proc Natl Acad Sci USA 100: 3027-30.
117. Ikeda T., Oosawa K., Hotani H. ( 1996) Self-assembly of the filament capping protein, FliD, of bacterial flagella into an annular structure. J Mol Biol 259: 679-86.
118. Arora S.K., Dasgupta N., Lory S., Ramphal R. ( 2000) Identification of two distinct types of flagellar cap proteins, FliD, in Pseudomonas aeruginosa. Infect Immun 68: 1474-9.
119. Arora S.K., Ritchings B.W., Almira E.C., Lory S., Ramphal R. ( 1998) The Pseudomonas aeruginosa flagellar cap protein, FliD, is responsible for mucin adhesion. Infect Immun 66: 1000-7.
120. Wilson R.K., Shaw R.K., Daniell S., Knutton S., Frankel G. ( 2001) Role of EscF, a putative needle complex protein, in the type III protein translocation system of enteropathogenic Escherichia coli. Cell Microbiol 3: 753-62.
121. Potter A.A., Klashinsky S., Li Y., Frey E., Townsend H., Rogan D., Erickson G., Hinkley S., Klopfenstein T., Moxley R.A., Smith D.R., Finlay B.B. ( 2004) Decreased shedding of Escherichia coli O157:H7 by cattle following vaccination with type III secreted proteins. Vaccine 22: 362-9.
122. Pallen M.J., Dougan G., Frankel G. ( 1997) Coiled-coil domains in proteins secreted by Type III secretion systems. Mol Microbiol 25: 423-5.
123. Derewenda U., Mateja A., Devedijiev Y., Routzahn K.M., Evodokimov A.G., Derewenda Z.S., Waugh D.S. ( 2004) The structure of Yersinia pestis V-antigen, an essential virulence factor and mediator of immunity against plague. Structure 12: 301-6.
124. Lupas A. ( 1996) Coiled coils: new structures and new functions. Trends Biochem Sci 21: 375-82.
125. Moriyama K., Wiener-Kronish J.P., Sawa T. ( 2009) Protective effects of affinity-purified antibody and truncated vaccines against Pseudomonas aeruginosa V-antigen in neutropenic mice. Microbiol Immunol 53: 587-94.
126. Kimbrough T.G., Miller S.I. ( 2000) Contribution of Salmonella typhimurium Type III secretion components to needle complex formation. Proc Natl Acad Sci USA 97: 11008-13.
127. Kubori T., Matsushima Y., Nakamura D., Uralil J., Lara-Tejero M., Sukhan A., Galan J.E., Aizawa S.I. ( 1998) Supramolecular structure of the Salmonella typhimurium type III protein secretion system. Science 280: 602-5.
128. Hoiczyk E., Blobel G. ( 2001) Polymerization of a single protein of the pathogen Yersinia enterocolitica into needles punctures eukaryotic cells. Proc Natl Acad Sci USA 98: 4669-74.
129. Espina M., Ausar S.F., Middaugh C.R., Baxter M.A., Picking W.D., Picking W.L. ( 2007) Conformational stability and differential structural analysis of LcrV, PcrV, BipD, and SipD from Type III secretion systems. Protein Sci 16: 704-14.
130. Broz P., Mueller C.A., Muller S.A., Philippsen A., Sorg I., Engel A., Cornelis G.R. ( 2007) Function and molecular architecture of the Yersinia injectisome tip complex. Mol Microbiol 65: 1311-20.
131. Blocker A.J., Deane J.E., Veenendaal A.K., Roversi P., Hodgkinson J.L., Johnson S., Lea S.M. ( 2008) What's the point of the Type III secretion system needle? Proc Natl Acad Sci USA 105: 6507-13.
132. Caroline G., Eric F., Bohn Y.S., Sylvie E., Attree I. ( 2008) Oligomerization of PcrV and LcrV, protective antigens of Pseudomonas aeruginosa and Yersinia pestis. J Biol Chem 283: 23940-9.
133. Chaudhury S., Battaile K.P., Lovell S., Plano G.V., De Guzman R.N. ( 2013) Structure of the Yersinia pestis tip protein LcrV refined to 1. 65 A resolution. Acta crystallogr Sec F Struct Biol Crystal Commun 69: 477-81.
134. Multiple Sequence Alignment by CLUSTALW. Kyoto University Bioinformatics Center. [Cited 1 Feb 2014.] Available from URL: http://www.genome.jp/tools/clustalw/.
135. Columbia University PredictProtein. [Cited 1 Feb 2014.] Available from URL: http://www.predictprotein.org/.
136. Combet C., Jambon M., Deleage G., Geourjon C. ( 2002) Geno3D: automatic comparative molecular modelling of protein. Bioinformatics 18: 213-4.
137. Open-Source Foundation PyMol.[Cited 1 Feb 2014.] Available from: http://pymol.org/.